• News and Press

The Latest News and Stories Related to the QuintilesIMS Institute

We’re still spending more on drugs, but annual cost increases are slowing

04-05-2017

STAT
In a significant shift, total spending on medicines in the US rose by 5.8 percent, to $450 billion, in 2016, which was less than half the rate seen in the last two years. In 2015, for instance, drug spending climbed 8.9 percent and it had rocketed up by 12 percent the year before.

Politicians are complaining more about the cost of drugs. The average patient is paying less.

04-05-2017

Washington Post
There's widespread outrage about soaring drug prices, but a new report shows that people are, on average, actually paying less for their medications than they did a few years ago.

U.S. Prescription Drug Spending as High as $610 Billion by 2021: Report

04-05-2017

Reuters
Spending on prescription medicines in the United States will increase 4-7 percent through 2021, reaching $580 billion to $610 billion, according to a report released by QuintilesIMS Holding (Q.N) on Thursday that lowered its prior long-term forecast.

Pricing furor aside, drug spending growth slowed last year—but still hit $323B

04-05-2017

FiercePharma
Despite what you may have heard about drug pricing and expenses getting out of hand, net spending growth actually fell in the U.S. last year. After discounts, pharmaceutical spending increased 4.8% in 2016, down from 8.9% growth recorded in 2015.

Drug Prices Are Growing At The Slowest Rate In Years. Here's Why It Doesn't Feel That Way

04-05-2017

Forbes
You’d think, from the political clamor, that the cost of prescription drugs is rising out of control. But actually, growth in drug prices this year was half of last year, according to a new report from The QuintilesIMS Institute, an arm of a gigantic pharmaceutical industry consulting firm. More than that, the average out-of-pocket cost to consumers has decreased.

Hard to Swallow: Cancer drugs are getting better and dearer

04-05-2017

Economist
The debate in rich countries about the high price of drugs is a furious and frustrating one. The controversy is already having an impact on spending on drugs, suggest new figures from the QuintilesIMS Institute, a research firm. 

See More

To learn more about ways that the QuintilesIMS Institute can support your initiatives, please reach out to our team:

 

*Required